Media coverage
19
Media coverage
Title Olipudase alfa shown to provide sustained improvement across multiple clinical manifestations of ASMD Media name/outlet Sanofi Country/Territory France Date 10/02/22 URL https://www.sanofi.com/en/media-room/press-releases/2022/2022-02-09-18-00-00-2382138 Persons Melissa Wasserstein Title Olipudase alfa shown to provide sustained improvement across multiple clinical manifestations of ASMD Media name/outlet MENAFN -Press Releases (English) Country/Territory Jordan Date 9/02/22 Persons Melissa Wasserstein Title Olipudase alfa shown to provide sustained improvement across multiple clinical manifestations of ASMD Media name/outlet Morningstar.com Country/Territory United States Date 9/02/22 URL https://www.morningstar.com/news/globe-newswire/1000603791/olipudase-alfa-shown-to-provide-sustained-improvement-across-multiple-clinical-manifestations-of-asmd Persons Melissa Wasserstein Title Olipudase alfa shown to provide sustained improvement across multiple clinical manifestations of ASMD Media name/outlet Street Insider Country/Territory United States Date 9/02/22 URL https://www.streetinsider.com/Press+Releases/Olipudase+alfa+shown+to+provide+sustained+improvement+across+multiple+clinical+manifestations+of+ASMD/19582846.html Persons Melissa Wasserstein Title Olipudase alfa shown to provide sustained improvement across multiple clinical manifestations of ASMD Media name/outlet Finanzen.net Country/Territory Germany Date 9/02/22 URL https://www.finanzen.net/nachricht/aktien/olipudase-alfa-shown-to-provide-sustained-improvement-across-multiple-clinical-manifestations-of-asmd-11019215 Persons Melissa Wasserstein Title Olipudase alfa shown to provide sustained improvement across multiple clinical manifestations of ASMD Media name/outlet Yahoo! Finance Country/Territory United States Date 9/02/22 URL https://finance.yahoo.com/news/olipudase-alfa-shown-sustained-improvement-170000983.html Persons Melissa Wasserstein Title Olipudase alfa shown to provide sustained improvement across multiple clinical manifestations of ASMD Media name/outlet ADVFN UK Country/Territory United Kingdom Date 9/02/22 URL https://uk.advfn.com/stock-market/EURONEXT/SAN/share-news/Olipudase-alfa-shown-to-provide-sustained-improvem/87233835 Persons Melissa Wasserstein Title Olipudase alfa shown to provide sustained improvement across multiple clinical manifestations of ASMD Media name/outlet Yahoo! Canada Country/Territory Canada Date 9/02/22 URL https://ca.sports.yahoo.com/news/olipudase-alfa-shown-sustained-improvement-170000983.html Persons Melissa Wasserstein Title Olipudase alfa shown to provide sustained improvement across multiple clinical manifestations of ASMD Media name/outlet ADVFN US Country/Territory United States Date 9/02/22 URL https://www.advfn.com/p.php?pid=nmona&article=87233791 Persons Melissa Wasserstein Title Olipudase alfa shown to provide sustained improvement across multiple clinical manifestations of ASMD Media name/outlet Ariva.de Country/Territory Germany Date 9/02/22 URL www.ariva.de/news/olipudase-alfa-shown-to-provide-sustained-improvement-across-9991956 Persons Melissa Wasserstein Title Olipudase alfa shown to provide sustained improvement across multiple clinical manifestations of ASMD Media name/outlet Spoke.com Country/Territory United States Date 9/02/22 URL https://www.spoke.com/press_releases/6203fe69fc32f5a005000602 Persons Melissa Wasserstein Title Olipudase alfa shown to provide sustained improvement across multiple clinical manifestations of ASMD Media name/outlet GlobeNewswire Country/Territory United States Date 9/02/22 URL https://www.globenewswire.com/news-release/2022/02/09/2382138/0/en/Olipudase-alfa-shown-to-provide-sustained-improvement-across-multiple-clinical-manifestations-of-ASMD.html Persons Melissa Wasserstein Title Olipudase alfa shown to provide sustained improvement across multiple clinical manifestations of ASMD Media name/outlet Thomson Reuters One Country/Territory United States Date 9/02/22 Persons Melissa Wasserstein Title Olipudase alfa shown to provide sustained improvement across multiple clinical manifestations of ASMD Media name/outlet PrimeNewswire (Top News) Country/Territory United States Date 9/02/22 Persons Melissa Wasserstein Title Olipudase alfa shown to provide sustained improvement across multiple clinical manifestations of ASMD Media name/outlet Investegate Country/Territory United Kingdom Date 9/02/22 URL https://www.investegate.co.uk/sanofi---aventis-groupe/gnw/olipudase-alfa-shown-to-provide-sustained-improvement-across-multiple-clinical-manifestations-of-asmd/20220209170000H3791/ Persons Melissa Wasserstein Title Sanofi SA: Olipudase alfa shown to provide sustained improvement across multiple clinical manifestations of ASMD (GlobeNewswire) Media name/outlet Avanza Bank AB Country/Territory Sweden Date 9/02/22 URL https://www.avanza.se/placera/pressmeddelanden/2022/02/09/sanofi-sa-olipudase-alfa-shown-to-provide-sustained-improvement-across-multiple-clinical-manifestations-of-asmd.html Persons Melissa Wasserstein Title Sanofi - Aventis Groupe: Olipudase alfa shown to provide sustained improvement across multiple clinical manifestations of ASMD Media name/outlet FinanzNachrichten.de Country/Territory Germany Date 9/02/22 URL https://www.finanznachrichten.de/nachrichten-2022-02/55200258-sanofi-aventis-groupe-olipudase-alfa-shown-to-provide-sustained-improvement-across-multiple-clinical-manifestations-of-asmd-399.htm Persons Melissa Wasserstein Title Olipudase alfa shown to provide sustained improvement across multiple clinical manifestations of ASMD Media name/outlet BizWire Express Country/Territory India Date 9/02/22 URL www.bizwireexpress.com/showstoryGNW.php?storyid=336644 Persons Melissa Wasserstein Title Olipudase alfa shown to provide sustained improvement across multiple clinical manifestations of ASMD Media name/outlet Hugin - English Country/Territory United States Date 9/02/22 Persons Melissa Wasserstein